Speaking Engagement

31st Annual Pharmaceutical / Chemical Patent Practice Update

Wednesday, November 08 1:00 PM EST to 6:30 PM EST

The tradition continues for the annual Pharmaceutical/Chemical Practice Seminar, back for its 31st Year!  Come hear practice tips, guidance, legal updates and summaries from leading experts.  The program will encompass a variety of cutting edge topics, including patent eligibility, inherent obviousness, criteria for injunctions, launch at risk, and inequitable conduct.

In addition to earning valuable CLE credits (and Ethics CLE), your program registration includes lunch, starting at noon, and two breaks, which are great opportunities to network with your fellow program participants and NJIPLA members.

Location:

APA Hotel Woodbridge120 Wood Avenue South, Iselin, NJ

CLE: All credits are pending confirmation. New Jersey & New York 4.5 Credits, including 1.0 Ethics CreditsPennsylvania 4.0 Credits, including 1.0 Ethics Credits

Topics and Speakers:

Patent Eligibility for Diagnostic Methods, Natural Products and Biotech Inventions Post-MyriadRyann M. Muir, Steptoe & Johnson LLP

Inherent ObviousnessPaul W. Browning, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Criteria for Preliminary and Permanent Injunctions for Pharma and Biotech Cases:  A Survey of Jurisdictions WorldwideOtto Licks, Licks Attorneys

Launch at Risk:  Brand and Generic PerspectivesChristopher E. Loh, Fitzpatrick, Cella, Harper & ScintoKyle Musgrove, Haynes and Boone, LLP

Recent Developments in Inequitable Conduct Law: Will Regeneron v. Merus Create a New Plague?Eric W. Dittmann, Paul Hastings LLP